Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now indicates that no participants are being recruited for the GAMMA-1 study. This clarifies that enrollment has ended and helps users understand the current participation status.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision tag at the bottom of the page has been updated from v3.5.3 to v3.5.4. This reflects a new version designation for the page.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision: v3.5.3 was added, replacing the previous v3.5.2. This indicates a small update to the page's documentation or UI.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.2 was added, replacing the previous v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision tag in the page footer updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.